Expression of major histocompatibility complex (MHC) class II molecules is developmentally regulated and lineage dependent. Their role in hematopoiesis is not well defined. Previous studies in a canine model showed that dogs given 920 cGy of total body irradiation. transplanted with autologous marrow, and treated with anti-MHC class II monoclonal antibody (MoAb) immediately posttransplant experienced only a transient granulocyte recovery that was followed by graft failure. In the present study, the effect of anti-MHC class II MoAbs on canine in vitro hematopoiesis was investigated. Anti-MHC class II MoAb H81.9 or B1F6 (both recognizing nonpolymorphic determinants) had no inhibitory effect when added directly t o colony-forming unit-granulocytemacrophage (CFU-GM) grown in agar. However, the addition of intact MoAb or as F(ab'), fragments t o long-term marrow cultures (LTMCs) resulted in a dose-dependent inhibition of the generation of CFU-GM among nonadherent cells. Inhibition was most profound with MoAb added at the time of initiation of culture. However, even if MoAb was added 3 weeks after recharging LTMCs. CFU-GM generation
Expression of major histocompatibility complex (MHC) class II molecules is developmentally regulated and lineage dependent. Their role in hematopoiesis is not well defined. Previous studies in a canine model showed that dogs given 920 cGy of total body irradiation. transplanted with autologous marrow, and treated with anti-MHC class II monoclonal antibody (MoAb) immediately posttransplant experienced only a transient granulocyte recovery that was followed by graft failure. In the present study, the effect of anti-MHC class II MoAbs on canine in vitro hematopoiesis was investigated. Anti-MHC class II MoAb H81.9 or B1F6 (both recognizing nonpolymorphic determinants) had no inhibitory effect when added directly t o colony-forming unit-granulocytemacrophage (CFU-GM) grown in agar. However, the addition of intact MoAb or as F(ab'), fragments t o long-term marrow cultures (LTMCs) resulted in a dose-dependent inhibition of the generation of CFU-GM among nonadherent cells. Inhibition was most profound with MoAb added at the time of initiation of culture. However, even if MoAb was added 3 weeks after recharging LTMCs. CFU-GM generation HE GENES and gene products of the major histocompatibility complex (MHC), termed HLA in humans' and DLA in the dog,* play a central role in the regulation of immune responses, immune-mediated diseases, and transplantation. The role of these genes in hematopoiesis is less well defir~ed.~.~ Although class I antigens are widely expressed on lymphohematopoietic cells, the expression of MHC class 11 is restricted, developmentally regulated, and inducible in a tissue and cell lineage-dependent fashion." Human hematopoietic progenitor cells, including colony-forming unit-granulocyte-macrophage (CFU-GM), burst-forming unit erythroid, and colony-forming unit granulocyte, erythroid, monocyte, megakaryocyte, express HLA-DR and -DP, whereas HLA-DQ antigens are la~king?~"'"~ Maturation of granulocytes is associated with a loss of cell surface expression of class I1 antigens, whereas expression is maintained on functionally mature monocytes and macrophages?,'' The current notion is that among adult human marrow cells, the earliest identifiable precursor cells are CD34TD38-lin-c-kit+ DR-.".I6 However, dependent upon culture conditions, a greater yield of long-term culture initiating cells may be derived from DR' than DR-precursors." In addition, Traycoff et a l l 8 have shown that long-term culture-initiating cells in human cord blood are CD34' DR'.
In some species such as the dog" or guinea pig:" MHC class I1 molecules are expressed rather broadly including, eg, resting T cells. In vitro cytolytic treatment of canine marrow with the murine anti-MHC class I1 monoclonal antibody (MoAb) 7.2 before autologous transplantation prevents hematopoietic reconstitution in lethally irradiated dogs." Conversely, positively selected (7.2') marrow cells are capable of sustained hematopoietic reconstitution." In more recent studies, we manipulated MHC class I1 gene products in vivo: Dogs given 920 cGy of total body irradiation and autologous marrow uniformly recover normal hematopoiesis; however, dogs that, in addition, are given anti-MHC T Blood, Vol86, No 9 (November l), 1995: pp 3341-3352 rapidly decreased. In addition, the number of adherent cells in LTMCs decreased; predominantly fibroblast-like cells with prominent cytoplasmic vesiculation remained. Acridine orangelethidium bromide staining and TdT-mediated deoxyuridine triphosphate-digoxigenin nick end labeling {TUNEL) tests showed an increase in the proportion of apoptotic cells in both the nonadherent and adherent compartments. Binding of anti-MHC class II MoAb t o unfractionated marrow cells resulted in an increase in free (Caa')i; no changes in tyrosine phosphorylation pattern were observed. The addition of stem cell factor (SCF), but not granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor, t o LTMCs prevented apoptosis, and the generation of CFU-GM was indistinguishable from controls. Similarly, a supportive adherent layer was maintained. Thus, anti-MHC class II MoAbs interfere with hematopoiesis both in vitro and in vivo. The mechanism involves programmed cell death in subpopulations of adherent and nonadherent cells. Inhibition of hematopoiesis is abrogated by exogenous SCF. 0 1995 by The American Society of Hematology.
class I1 MoAb immediately posttransplant (days 0-4) show only a transient increase in granulocytes after the postirradiation nadir, which is followed by graft failure and marrow aplasia.*> These findings suggest that MHC class 11' cells either with hematopoietic or accessory function and required for sustained hematopoietic recovery, are inhibited by the administration of anti-MHC class I1 MoAb. Alternatively, MHC class 11-mediated signals may interfere with hematopoiesis via downregulation of hematopoietic growth factors or induction of negative regulators of hematopoiesis.
Long-term marrow culture (LTMC) systemsz4 provide useful in vitro models of hematopoiesis. These cultures are dependent on the establishment of a complex adherent layer composed of both hematopoietic precursor cells and stromal cells that simulate the marrow microenvironment?'2h With MHC class I1 framework determinant^."^'^ B I F6 (IgG2a) recognizes canine MHC class I1 framework determinants and is cross-reactive with HLA-DR and -DP." F(ab')' fragments of H8 I .9 were obtained by digestion with pepsin and purification over protein-A columns as described.'" MoAb G3G6 (IgG2a). specific for the human plateletassociated glycoprotein lIb/llla (C. Badger, unpublished observations, 1994) and nonreactive with canine cells, was used as control. MoAbs were purified from murine ascites or obtained from supernatant of hybridoma grown in the Fred Hutchinson Cancer Research Center bioproduction facility. The MoAbs were characterized by standard techniques and shown to be free of mycoplasma contamination as described."
LTMCs
Bone marrow (BM) aspirates were obtained from the humerus of anesthetized normal dogs, and LTMCs were established as described." Briefly, mononuclear marrow cells (MNCs; 2 X IO') were cultured in 25-cm' tissue culture flasks (Costar, Cambridge, MA) in RPMI-I640 medium (MA Bioproducts, Walkerville, MD), supplemented with 20% prescreened heat-inactivated horse serum, IO-' moln hydrocortisone91 phosphate (Sigma Chemical CO, St Louis, MO), I % nonessential amino acids, I% pyruvate, 2% glutamine, and 1% penicillin-streptomycin. Cultures were maintained at 37°C in a humidified atmosphere of 5% CO, in air. After I week, nonadherent cells were removed, and half of the spent medium plus an equal volume of fresh medium and freshly aspirated autologous marrow buffy coat cells were recharged onto the adherent layers. Anti-MHC class I1 MoAb was added into flasks either upon initiation of culture or at the time of recharging. In some experiments, MoAb was added to cultures 6 days after recharging, ie, 24 hours before assaying nonadherent cells for colony formation in semisolid agar. Starting I week after recharging, nonadherent cells were procured at weekly intervals, pelleted, and counted, and aliquots were assayed for CFU-GM. The remaining cells were returned to the long-term culture flasks with spent medium and fresh medium mixed I : I . scribed." MNCs, 7.5 X IO4, were cultured for 14 days at 37°C in a humidified atmosphere of 5% CO, in air in 35-mm Petri dishes containing 2 mL of agar medium. The agar medium consisted of an equal volume mixture of 0.6% (wthol) Bacto agar (Difco, Detroit, MI) and double-strength Dulbecco's modified Eagle's medium (GIBCO, Grand Island, NY) containing 40% (vollvol) heat-inactivated prescreened human AB plasma. Three replicate cultures per test were assayed. The morphology of cells in the colonies was determined on cytospin preparations of individually picked colonies stained according to Wright-Giemsa (Sigma, St Louis, MO). In addition, fresh marrow MNCs, either unmanipulated or incubated with MoAb for 30 or 60 minutes before being placed in culture, were assayed for CFU-GM.
CFU-GM Assay

Hematopoietic Growth Factors
Recombinant canine c-kif ligand (stem cell factor; rcSCF), rc granulocyte-macrophage colony-stimulating factor (rcGM-CSF), and rc granulocyte colony-stimulating factor (rcG-CSF) were provided by Amgen Inc (Thousand Oaks, CA). These factors were used at concentrations determined in ancillary studies: SCF at 1 to 500 ng/mL, GM-CSF at 10 to 1 0 0 nglmL, and G-CSF at 1 0 0 to 500 ng/mL. In various LTMC experiments, either one of these factors was added alone or in conjunction with anti-MHC class I1 MoAb with the aim of determining whether the MoAb-mediated effect was abrogated.
Morphologic Studies on LTMC
Lighr microscopy (LMJ. In addition to standard culture flasks, LTMCs were established on chamber slides in flaskettes with I-cm' wells (Nunc, Naperville, IL), as described.'> After I week in culture, the nonadherent cells were removed, and fresh autologous marrow buffy coat cells were recharged onto the adherent layers as described above, and anti-MHC class I1 MoAb was added at various time intervals. The adherent stromal layers were examined by LM. Additional slides were stained with acridine orange and ethidium bromide or examined by TdT-mediated deoxyuridine triphosphate-digoxigenin nick end labeling (TUNEL; Apop Tag Kit; OnCor Inc, Gaithersburg, MD) test to examine for apoptotic changes (see below).l4
Electron microscopy. Canine marrow MNCs were procured as described on chamber slides in flaskettes with I-cm' wells and cultured in the presence of anti-MHC class I1 MoAbs. Stromal cells For personal use only. on October 31, 2017. by guest www.bloodjournal.org From MoAb H81.9 plus SCF (10 ng/mL). Although H81.9-treated flaskettes show a loss of adherent cells relative t o controls, the addition of SCF concurrently with H81.9 prevented adherent cell loss; in fact, adherent cells appeared larger and showed a tendency toward cluster formation.
were fixed in Kamovsky'slKamosky2, washed in 1% OsO, for I hour on ice, and then dehydrated in sequential ethanol series and embedded. The sections were placed on copper grids and stained with uranyl acetate and lead citrate, and examined on a JEOL 1 0 0 SX electron microscope."
Immunoprecipitation and lmmunoblots
Cells were lysed on ice with NP-40 lysis buffer and centrifuged at 13,OOOg to remove insoluble material as described.35 Immunopre-HONG ET AL cipitation of phospholipase C (PLC) yl was performed as described.'" Immune complexes were collected on protein A-sepharose beads, washed, subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis.'5 lmmunoblots with anti-PLCy1 and antiphosphotyrosine were performed and antibody binding detected using '"l protein A and autoradiography as described."'."
Measurement of Cytoplasmic Calcium Ion [(Ca")i] Concentration
Ca" ion flux in indo-l (Molecular Probes, Eugene, OR) loaded cells was measured with a model 50 HH12150 flow cytometer (Ortho, Westwood, MA) as described.'"'" Briefly, canine mononuclear cells were loaded with indo-l acetoxymethyl ester by incubation for 5 minutes ar 37T, followed by incubation on ice at 4°C. Cells were then washed and resuspended in fresh medium and stored in the dark on ice until analysis. The modification of maintaining cells at 4°C rather than 37°C or room temperature. as is customary with staining. Cell morphology was evaluated on May-GriinwaldGiemsa-stained cytocentrifuged cell preparations. Apoptotic cellular changes were identified as described considering cell membrane alterations, chromatin condensation, and nuclear fragmentation?'. '' In addition, the TUNEL test was applied to anti-MHC class I1 MoAb-treated nonadherent and adherent cells. Cultured nonadherent cells and adherent cells detached by treatment with trypsin (0.05%; S minutes) were centrifuged for 4 minutes at 4 0 0~ at room temperature. The supernatant was discarded, and the pellet was resuspended in the remaining medium. Four percent formalin was added to the suspension. Drops of the cell suspension were placed on slides precoated with 0.01% poly-L-lysine and air dried. TdT labeling was performed as described by Gavrieli et a1,'4 except that peroxidase was developed with diaminobenzene. Slides were counterstained with methyl green.
Flow Cytometric Analysis of Apoptosis in LTMCs
To further quantitate anti-MHC class 11 MoAb-mediated apoptosis, a flow cytometric analysis of propidium iodide (PI)-stained cells was used with modifications as described?' After various incubation times after recharging in LTMC, nonadherent and adherent cells were washed and pelleted, and the pellet gently resuspended in I mL hypotonic PI solution (Sigma ~1 3 0 4 , 1 0 0 &mL; 0. I '% sodium citrate, 0.1% Triton X-100; Ribonuclease A: Sigma R 4875.0. I mg/mL). Samples were allowed to equilibrate for at least I hour in the dark before analysis. Fluorescence analysis of individual nuclei was performed with the use of a FACScan flow cytometer equipped with an argon laser at 488 nm and 250 mW light output and lysis I1 software (Becton Dickinson, San Jose, CA). The fluorescence intensity from cell nuclei stained with PI is proportional to the cellular DNA content. Events ( I O X IO4) were collected, stored, and analyzed by Multicycle software developed by Dr P. Rabinovitch (University of Washington, Seattle, WA).
Transmission Electron Microscopy of Apoptosis in LTMCs
Cultured nonadherent and adherent cells were collected by scraping with Cell Scraper (Baxter, McGaw Park, IL) in the presence of MoAb H81.9 alone or MoAb H81.9 plus SCF, and washed in phosphate-buffered saline (PBS). After washing, the cells were fixed 
In Vitro Hematopoiesis is Inhibited by Anti-MHC Class II MoAbs
Incubation of MNCs with MoAb H81.9 or BlF6 for 30 minutes or 1 hour before being placed in culture did not effect CFU-GM colony formation; only pretreatment of cells with MoAb plus complement reduced the number of CFU-GM (Table 1) . However, if MoAb [intact or as F(ab'), fragments] was added to LTMCs, the ability of nonadherent cells to form CFU-GM was inhibited in a dose-dependent fashion (Fig 1) . Inhibition was most profound with MoAb added at the time of initiation of cultures and less so when MoAb was added later (Fig 2) . Considering the possibility that the early presence of MoAb would not allow for the establishment of a functional adherent layer and normal contact to nonadherent cells, an adherent layer was established, recharged with nonadherent cells 1 week later, and cultures were left unperturbed for 2 weeks before H81.9 (10 pg/ml) was added. Beginning again l week later, nonadherent cells were assayed for CFU-GM. As with the earlier addition of MoAb, CFU-GM formation decreased to unmeasurable numbers by 3 weeks (not shown).
Anti-MHC Class I1 MoAb-Mediated Loss of Adherent Layers
As shown in Fig 3, in the presence of MoAb H81.9 there was a progressive decrease in the density of adherent cells in LTMCs. By light and electron microscopic examination, remaining cells showed fibroblastoid characteristics. Furthermore, adherent cells in MoAb-treated cultures contained more prominent cytoplasmatic vesicles than did cells in nontreated cultures (Fig 4) .
Effect of Recombinant Growth Factor on Anti-MHC Class I1 MoAb-Mediated Inhibition of LTMCs
Previous studies had shown that dogs treated with MoAb H81.9 were rescued from graft failure if treated with exoge- nous SCF concurrently with MoAb administration, even though the kinetics of hematopoietic recovery were not completely normal?' Therefore, we attempted to characterize a comparable effect of SCF (or other growth factors) in vitro. Three canine factors available in recombinant form (G-CSF, GM-CSF, and SCF)44.45 were tested (Fig 5) . The presence of exogenous G-CSF or GM-CSF in MoAb-treated cultures had no recognizable effect. However, SCF at 10 ng/mL or higher completely prevented a decrease in CFU-GM that were cultured from nonadherent cells. In addition, the adherent layer of SCF-treated cultures was largely maintained and showed a prominence of large fibroblast-like cells with a tendency to form clusters with nonadherent cells.
Anti-MHC Class II MoAb Treatment and Transmembrane Signaling
Anti-MHC class I1 MoAbs, somewhat dependent upon the recognized epitope, mediate transmembrane signals and trigger Ca2' mobilization in lymph~cytes.'~.~~ We hypothesized that similar events occur in canine marrow cells.
BM mononuclear cells were incubated with intact anti-MHC class I1 MoAb (H81.9, BIF6, CA1.41, HBlOa, p4.1) alone or in combination or with F(ab'), fragments of H81.9.
After 2 and 5 minutes, samples were procured and assayed for tyrosine phosphorylation. No new protein bands and no significant changes in the intensity of preexisting proteins were detectable (Fig 6) .
Next, marrow mononuclear cells, loaded with indo-l, were treated with biotin-conjugated anti-MHC class I1
MoAb. There was no detectable change in [Ca*']i with the MoAb alone; a moderate signal was observed after crosslinking of biotin-conjugated H81.9 with avidin (Fig 7) . Thus, these results showed calcium signaling, but suggested that a pathway other than tyrosine phosphorylation was involved.
Apoptosis in LTMCs
Nonadherent and adherent cells from LTMCs were stained with acridine orange/ethidium bromide or alternatively subjected to the TUNEL method at various time points after addition of MoAb H81.9 to cultures. Results are illustrated in Fig 8. As expected, some apoptotic nuclei were seen even in control cultures. However, the proportion of cells showing apoptosis was increased in MoAbtreated LTMCs, both in the adherent and the nonadherent Nonadherent and adherent cells from LTMCs were also analyzed for DNA content by flow cytometry (Fig 9) . Beginning at 3 to 4 hours, apoptotic cell nuclei were de- tectable. Apoptotic nuclei were seen among both adherent and nonadherent cells. The proportions varied slightly from experiment to experiment (ranging from 6% to 15%) and reached a plateau at 24 hours. The concurrent presence of exogenous SCF consistently reduced or prevented the development of apoptosis. As shown in Fig IO, after autologous marrow transplantation.2'.22 Recently, we observed that dogs given marrow-ablative doses of total body irradiation (920 cGy) and infused with unmanipulated autologous marrow fail to recover normal hematopoiesis and die with marrow aplasia if treated with anti-MHC class I1 MoAb in the immediate posttransplant period (days 0 through 4)." To further investigate these observations, the present in vitro studies were undertaken.
The addition of anti-MHC class I1 MoAb to LTMCs resulted in a dose-dependent decrease of CFU-GM precursors among nonadherent cells. This was of note because no significant effect of these MoAbs was observed when added directly to CFU-GM cultures in agar. Although it is possible that, in a semisolid medium, MoAb would not be freely available and CFU-GM would not be exposed to concentrations sufficient for inhibition, this is unlikely because even MoAb concentrations 20-fold higher than used in LTMCs did not result in direct CFU-GM inhibition, and preincubation of CFU-GM with MoAb failed to result in an inhibitory effect. Thus, these results suggest that the anti-MHC class I1 MoAb exerted its effect not directly on CFU-GM, but rather on a less mature precursor cell or, alternatively, on nonhematopoietic accessory cells. These cells would be expected to express class I1 molecules. Indeed, morphologic analyses in the present study showed that anti-MHC class I1 MoAb interfered with the development of a normal functional adherent layer, a finding in agreement with observations by Briihl et al who had shown that the presence of anti-HLA-DR and -DP MoAb prevented the formation of confluent adherent layers in human in vitro models." Those results were surprising because MHC class 11 antigens are generally thought to be expressed minimally or not at all?'.s3 They are, nevertheless, consistent with the finding that at Consistent with the notion that subpopulations of cells are affected by anti-MHC class I1 MoAb is the analysis of apoptosis, showing that only a proportion of cells, both adherent and nonadherent, was involved. Apoptosis has been observed in B lymphocytes exposed to MoAbs directed at MHC class I1 and could be prevented by interleukin-4." Binding of MoAb to class I1 antigens has also been shown to induce tyrosine phosphorylation and C& flux in T lymphocytes." Superantigen-induced apoptosis of class I' T cells is at least partially mediated by early class I1 signals from tyrosine kinase activation, but is also dependent upon late adhesion through beta-2 integrins."." Experiments on transmembrane signaling in the present study showed evidence for class 11-mediated calcium signals, although no change in tyrosine phosphorylation was seen in whole cell lysates. The role of adhesion, clearly MHC class I1 inducible in B cell^^'^^^ remains to be determined in the present model.
Regardless of the pathway, MoAb-mediated apoptosis and inhibition of hematopoiesis were prevented by exogenous SCF. Williams et al first reported that growth factor withdrawal from hematopoietic cultures in vitro resulted in apoptosisy and others showed that apoptosis in human erythroid progenitors was prevented or reduced by SCF even in the absence of erythropoietin."." However, there is no direct evidence that both MHC class 11 and c-kit-dependent signals are mediated through the same cell. In fact, semiquantitative dilution experiments with highly enriched human CD34' cells assayed for colony formation in the absence or presence of MoAb H8 1.9 suggest that an accessory cell is involved in the MHC-mediated effect."' Such a hypothesis is also consistent with observations in the present study: anti-MHC class I1 MoAb-triggered apoptotic cell death was present in adherent and nonadherent cells; however, the addition of SCF maintained viability predominantly among nonadherent cells. This could be readily explained by an effect of MoAbs on accessory cells in the adherent compartment, which serve as a source of SCF. Loss of those cells, in turn, would result in cell death among nonadherent cells. The addition of exogenous SCF would primarily affect SCF-dependent nonadherent cells and much less so the adherent layer, although the SCF receptor c-kit appears to be expressed on certain stromal cells."' Such a scenario would also accommodate in vivo observations": while the administration of SCF abrogated marrow failure in H81.9-treated dogs, a secondary decrease in granulocytes after the transient initial recovery was not completely prevented. These kinetics are consistent with recovery from a small pool of surviving stem cells rather than complete prevention of H81.9-induced damage.
Interestingly, the addition of G-CSF or GM-CSF to LTMCs failed to show any effect on stromal cells or hematopoiesis in the presence of anti-MHC class I1 MoAbs, suggesting that to overcome inhibition of hematopoiesis by anti-MHC class 11 MoAb, an early acting viability maintaining For personal use only. on October 31, 2017. by guest www.bloodjournal.org From factor such as SCF is required. If MoAb-mediated inhibition of hematopoiesis involves downregulation of growth factors, G-CSF and GM-CSF are unlikely candidates. In fact, preliminary data described elsewhere are consistent with this interpretation insofar as, at least at the mRNA level, G-CSF is not affected by anti-class I1 treatment, and GM-CSF i s upregulated." However, stromal cells are also a major source of SCF,6s,66 and, particularly under stress conditions, optimum support of hematopoiesis by the stromal layer is required. Neta et a16' have recently shown in mice that postirradiation hematopoietic recovery is impaired by treatment with anti-SCF antibody. Similarly, we have shown that neutralization of SCF in LTMCs using a specific MoAb results in exhaustion of hematopoiesis."
In conclusion, anti-MHC class 11-mediated inhibition of hematopoiesis and abrogation by the c-kit ligand SCF involves a complex mechanism, Programmed cell death represents one component. Additional factors include stromal cell dysfunction and dysregulation of growth factors.
